Concepedia

Author

Mark A. Giembycz

Lung Institute

Also Known As

Giembycz, Mark A., MARK A. GIEMBYCZ, Mark A GIEMBYCZ, Mark A Giembycz, Mark A. GIEMBYCZ, Mark A. Giembycz, Mark Anthony Giembycz, Mark Giembycz

212

Publications

9.5K

Citations

47

H-Index

72

Concepts

All Affiliations

Lung InstituteUniversity of CalgaryImperial College LondonTampere University Hospital
MA

About

Mark A. Giembycz is an author at Lung Institute specializing in medicine, immunology, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

32

1.8K

2

Allergy

10

10

653

3

Natural Sciences

3

3

107

4

Engineering

1

1

36

5

Health Sciences

1

1

80

Mark A. Giembycz

×

85

Publications

4.5K

Citations

41

H-Index

YearCitations

Neutrophil Chemotactic Activity of Sputum From Patients With COPD

Kai Michael Beeh, Oliver Kornmann, Roland Buhl,

CHEST Journal

2003

230

Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4<sup>+</sup>and CD8<sup>+</sup>T‐lymphocytes: role in regulating proliferation and the biosynthesis of interleukin‐2

Mark A. Giembycz, Christopher J. Corrigan, Joachim Seybold,

British Journal of Pharmacology

1996

216

Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages

Andrew J. Thorley, Paul A. Ford, Mark A. Giembycz,

The Journal of Immunology

2007

203

Delayed eosinophil apoptosis in asthma

Hannu Kankaanranta, Mark A. Lindsay, Mark A. Giembycz,

Journal of Allergy and Clinical Immunology

2000

176

Long-Acting β2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells

Manminder Kaur, Joanna E. Chivers, Mark A. Giembycz,

Molecular Pharmacology

2007

165

Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a Selective Inhibitor of Phosphodiesterase 7: In Vitro Studies in Human Monocytes, Lung Macrophages, and CD8+ T-Lymphocytes

Susan J. Smith, L B Cieslinski, Robert Newton,

Molecular Pharmacology

2004

164

Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitors

Gordon Dent, Mark A. Giembycz, Klaus F. Rabe,

British Journal of Pharmacology

1991

141

Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone

Michael A. Saunders, Jane A. Mitchell, Paul M. Seldon,

British Journal of Pharmacology

1997

125

Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells

Susan J. Smith, Steven Brookes-Fazakerley, Louise Donnelly,

American Journal of Physiology-Lung Cellular and Molecular Physiology

2003

121

Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E<sub>2</sub> inhibits lipopolysaccharide‐induced tumour necrosis factor‐<i>α</i> generation

Koremu Meja, Peter J. Barnes, Mark A. Giembycz

British Journal of Pharmacology

1997

105

Page 1